Hester Biosciences informs about outcome of board meeting

08 Aug 2023 Evaluate
With reference to letter dated 31 July 2023 intimating the date of the Board Meeting for consideration of the unaudited standalone and consolidated financial results for the quarter ended 30 June 2023 and pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has informed that Board of Directors, in its Meeting held today, have approved the unaudited standalone and consolidated financial results for the quarter ended 30 June 2023, as recommended by Audit Committee. It attached approved unaudited standalone and consolidated financial results and limited review reports. A Press Release issued in this regard will be publishing an extract of the results in the newspaper as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board Meeting commenced at 11:03 am (IST) and concluded at 12:01 pm (IST).

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

2395.85 25.70 (1.08%)
23-Dec-2024 09:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.55
Dr. Reddys Lab 1345.00
Cipla 1458.85
Lupin 2135.95
Zydus Lifesciences 964.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.